Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitorsEditorial Published on 2024-06-072024-09-05 Journal: World journal of gastroenterology [Category] update2024, [키워드] Bruton tyrosine kinase inhibitors hematologic malignancies Hepatitis B virus reactivation Prophylaxis guidelines solid tumors [DOI] 10.3748/wjg.v30.i21.2748 PMC 바로가기 [Article Type] Editorial
Neoantigen cancer vaccines: a new star on the horizonReview Published on 2024-04-152024-09-05 Journal: Cancer Biology & Medicine [Category] update2024, [키워드] AI bioinformatics High-throughput sequencing HLA Immunotherapy neoantigen cancer vaccine PDOs solid tumors TCR [DOI] 10.20892/j.issn.2095-3941.2023.0395 PMC 바로가기 [Article Type] Review
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective studyResearch Published on 2024-01-202024-09-05 Journal: Clinical and experimental medicine [Category] update2024, [키워드] active treatment COVID-19 vaccine herpes zoster SARS-CoV-2 solid tumors T cell third dose [DOI] 10.1007/s10238-023-01263-2 PMC 바로가기 [Article Type] Research
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study활동적으로 치료받고 있는 암 환자에서 SARS-CoV-2 mRNA-BNT162b2 백신의 세 번째 접종 후 대상포진: 전향적 연구Article Published on 2024-01-202024-08-16 Journal: Clin Exp Med [Category] 대상포진, [키워드] active treatment COVID-19 vaccine herpes zoster SARS-CoV-2 solid tumors T cell third dose
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumorsarticle Published on 2024-01-022024-09-04 Journal: The oncologist [Category] 대상포진, [키워드] cyclin-dependent kinase 7 cyclin-dependent kinase inhibitor Phase I solid tumors [DOI] 10.1093/oncolo/oyad215 PMC 바로가기 [Article Type] article
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical OncologyOriginal Research Article Published on 2023-08-102024-09-04 Journal: Tumori [Category] 대상포진, [키워드] COVID-19 herpes zoster palliative and supportive care solid tumors Vaccine hesitancy vaccine-preventable diseases VPDs [DOI] 10.1177/03008916231191547 PMC 바로가기 [Article Type] Original Research Article
Clinical and imaging experience with COVID-19 in nonvaccinated children with cancerResearch article Published on 2022-10-012022-10-05 Journal: Clinical imaging [Category] 치료기술, [키워드] abnormality Cancer cancer diagnosis children children with COVID-19 clinical Clinical data Clinical outcome Cohort complications COVID-19 death hematologic Hematologic malignancy higher risk imaging imaging abnormality less Observational data outcome recorded separated solid malignancies solid tumors two subgroup vaccination with COVID-19 [DOI] 10.1016/j.clinimag.2022.07.002 [Article Type] Research article
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study고형암 환자에서 SARS-CoV-2 백신접종에 대한 혈청학적 반응에 영향을 미치는 요인: 전향적 연구Observational Study Published on 2022-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] addition affecting analyzed Anti-SARS-CoV-2 S antibody antibody level Antibody test baseline blood sample BNT162b2 Cancer Chemotherapy CLIA clinical feature clinical study collected CoronaVac CoronaVac. COVID-19 demographic determine diagnoses dose enzyme evaluate Factor first dose IgG antibody IgG level immunoassay in both groups inactivated men mRNA vaccine of BNT162b2 oncology Patient Patients with cancer positive preventive measure proportion Prospective Study Quantitative RBD receiving Receptor binding domain SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 PCR SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Serologic response Sex significantly significantly higher single-center study solid tumor solid tumors vaccination Vaccine Vaccines virus spike protein was determined were excluded were measured [DOI] 10.1016/j.jiac.2022.05.021 PMC 바로가기 [Article Type] Observational Study
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies혈액암이 있는 성인 환자의 SARS-CoV-2 백신 1차 및 2차 접종에 대한 면역 반응의 체계적인 검토 및 메타 분석Review Published on 2022-09-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% confidence interval 95%CI affected affecting anti-CD20 therapy antibody Antibody detection Antibody Response article booster dose booster doses calculated Cancer patients chronic lymphocytic leukemia CLL Complete conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines develop Diagnosis disease doses evaluate first dose Google Google Scholar healthy subject healthy subjects Hematological malignancies Hematological malignancy higher risk highlight highlighting immune response Immunity immunization Immunocompromised immunogenicity immunosuppressive IMPROVE kinase inhibitors less leukemia lowest Lymphocytic leukemia lymphoma malignancy measure Meta-analysis mRNA mRNA-1273 Myeloma Patient Primary outcome response rate SARS-CoV-2 SARS-CoV-2 vaccine second dose secondary outcome Secondary outcomes seropositive Seropositivity severe coronavirus disease solid tumor solid tumors status subgroup subtype systematic review the disease the vaccine tumors tyrosine tyrosine kinase inhibitor tyrosine kinase inhibitors Vaccine vaccine dose vaccine's immunogenicity Web of Science [DOI] 10.1016/j.intimp.2022.109046 PMC 바로가기 [Article Type] Review
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccinesmRNA 백신 추가 접종 후 활성 요법을 받는 암 환자의 SARS-CoV-2 감염Article Published on 2022-08-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] active treatment anti-Spike IgG booster booster dose Booster vaccine cancer patient Cancer patients center Cohort COVID-19 Delta dose Follow-up geometric mean geometric mean titer geometric mean titers Health care Health care worker healthy subject healthy subjects indicate investigated Italy lowest malignancies median value microneutralization Microneutralization assay mRNA vaccine mRNA vaccines Nasopharyngeal swab Neutralizing antibodies neutralizing antibody Occurrence occurrence of COVID-19 omicron Omicron variants outbreak Patient positive potential risk proportion protective role required SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants serological Siena solid malignancies solid malignancy solid tumor solid tumors tested the median the SARS-CoV-2 therapy Treatment tumors Type university Vaccine variants [DOI] 10.1016/j.ejca.2022.05.018 PMC 바로가기 [Article Type] Article